Modifiable Risk Factors that Impact Myeloma (Part 1) image

Modifiable Risk Factors that Impact Myeloma (Part 1)

Jan 26, 2021
11:00AM - 12:00PM MST
Online Event
Overview
For the launch of our Nutrition and Wellness for Myeloma Chapter, we have invited Dr. Urvi Shah to speak to us. What modifiable risk factors are in your control? What questions do you have about metabolic disorders such as obesity or diabetes, the microbiome, or proper nutrition for plasma cell disorders? Sign up today for part one of our two-part series with Dr. Shah.
Agenda
11:00 AM
Introductions
Audrey Burton-Bethke
The purpose of the chapter is introduced. Dr. Urvi Shah is also introduced. 
11:05 AM
Presentation
Dr. Urvi Shah
Dr. Urvi Shah shares what modifiable risk factors are in your control. 
11:45 AM
Questions and Answers
Audience
Type your questions into the Q&A Section and we will answer as many as we can! 
Speakers & Moderators
Healthtree contact Audrey Burton-Bethke

Audrey Burton-Bethke

Audrey joined the Myeloma Crowd as the Community Manager in 2020 after previously working in the nonprofit field for 4 years as a director of Fundraising and Development. She graduated from BYU with a major in Spanish and Nonprofit Management. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Healthtree contact Urvi Shah, MD

Urvi Shah, MD

Dr. Urvi Shah is a faculty on the myeloma service, division of hematologic malignancies at Memorial Sloan Kettering Cancer Center. Her research focuses on studying the role of diet, microbiome, and other lifestyle-related risk factors in plasma cell disorders as well as identifying interventions to improve outcomes for these patients. She also studies immune therapies (including CAR T cell therapies) for myeloma. Being a lymphoma survivor herself she is passionate about helping patients make wise nutritional and lifestyle choices as they face a plasma cell disorder diagnosis as well as raising awareness about healthy choices to prevent cancer.